Wikidata entity: Q275926
C₁₇H₂₀N₂O₅S (P274)
Quantities
| P4250 | defined daily dose | 1 |
| P2067 | mass | 364.109293 |
| P233 | canonical SMILES | String | CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2 | ??? |
| P373 | Commons category | String | Bumetanide | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P1987 | MCN code | String | 2935.90.95 | ??? |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q147778 (liver cirrhosis) | liver cirrhosis |
| P2175 | medical condition treated | ... | Q486485 (anasarka) | anasarka |
| P2175 | medical condition treated | ... | Q504790 (nephrotic syndrome) | nephrotic syndrome |
| P2175 | medical condition treated | ... | Q736715 (chronic renal insufficiency) | chronic renal insufficiency |
| P2175 | medical condition treated | ... | Q857667 (pulmonary edema) | pulmonary edema |
| P2175 | medical condition treated | ... | Q929737 (liver disease) | liver disease |
| P2175 | medical condition treated | ... | Q19000661 (congestive heart failure) | congestive heart failure |
| P129 | physically interacts with | ... | Q21110936 (G protein-coupled receptor 35) | G protein-coupled receptor 35 |
| P129 | physically interacts with | ... | Q21119653 (Solute carrier family 12 member 2) | Solute carrier family 12 member 2 |
| P129 | physically interacts with | ... | Q21124409 (Solute carrier family 12 member 1) | Solute carrier family 12 member 1 |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q568 (lithium) | lithium |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q192717 (streptomycin) | streptomycin |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q241006 (desmopressin) | desmopressin |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q408529 (amikacin) | amikacin |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q412666 (ramipril) | ramipril |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q421119 (captopril) | captopril |
| P769 | significant drug interaction | ... | Q422185 (enalapril) | enalapril |
| P769 | significant drug interaction | ... | Q422222 (digoxin) | digoxin |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q425293 (fosinopril) | fosinopril |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q596022 (quinapril) | quinapril |
| P769 | significant drug interaction | ... | Q929420 (trandolapril) | trandolapril |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q1758380 (tobramycin) | tobramycin |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q47495698 (lisinopril dihydrate) | lisinopril dihydrate |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q200656 (diuretic) | diuretic |
| P2868 | subject has role | ... | Q50430324 (sodium potassium chloride symporter inhibitors) | sodium potassium chloride symporter inhibitors |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | bumetanide | ??? |
Why not click here or view trends?
log id: 5892040